Mnemo Therapeutics is a biotechnology company focused on developing powerful cell therapies that create accessible cures for solid tumors and blood cancers. Its EnfiniT platform, a groundbreaking drug discovery engine, leverages a new class of antigens with greater tumor specificity and a suite of technologies to significantly improve T cell memory, persistence, and sensitivity. The result is dramatic improvement in the body’s immune response to overcome disease. Mnemo is built by a transatlantic team of scientists and biotech leaders united in their mission to create the most powerful immune therapies to deliver accessible cures for all patients in need.

Biotechnology

Mnemo Therapeutics

Robert Lacaze

Ikram H.

Theodoros Giavridis

Michael Saitakis

Nil Ege

Bertrand Vannier

Justin Eyquem

Bénédicte Balland

Christine Foster

Nadia Kaci-Chaouche

Alain Maiore

Mariana Gajardo

Mnemo Therapeutics was founded by a team with experience in academia and industry. The team includes an assistant professor from University of California, San Francisco, a postdoctoral research fellow from Memorial Sloan Kettering Cancer Center, and an intern from University of Amsterdam.

Founding Team

Leadership Team

Board of Directors

Founding Team

About

Team members

Other teams at Mnemo Therapeutics

Leadership Team

Board of Directors